Brewin Dolphin Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $19K | Hold |
300
| – | – | ﹤0.01% | 241 |
|
|
2022
Q1 | $18K | Hold |
300
| – | – | ﹤0.01% | 260 |
|
|
2021
Q4 | $22K | Hold |
300
| – | – | ﹤0.01% | 253 |
|
|
2021
Q3 | $21K | Hold |
300
| – | – | ﹤0.01% | 259 |
|
|
2021
Q2 | $20.7K | Hold |
300
| – | – | ﹤0.01% | 263 |
|
|
2021
Q1 | $19.4K | Hold |
300
| – | – | ﹤0.01% | 256 |
|
|
2020
Q4 | $17.5K | Sell |
300
-140
| -32% | -$8.16K | ﹤0.01% | 232 |
|
|
2020
Q3 | $27.8K | Buy |
440
+300
| +214% | +$19K | 0.01% | 200 |
|
|
2020
Q2 | $10.8K | Sell |
140
-3,570
| -96% | -$275K | ﹤0.01% | 249 |
|
|
2020
Q1 | $277K | Hold |
3,710
| – | – | 0.15% | 64 |
|
|
2019
Q4 | $241K | Sell |
3,710
-250
| -6% | -$16.2K | 0.11% | 68 |
|
|
2019
Q3 | $251K | Sell |
3,960
-400
| -9% | -$25.4K | 0.13% | 65 |
|
|
2019
Q2 | $295K | Sell |
4,360
-240
| -5% | -$16.2K | 0.15% | 63 |
|
|
2019
Q1 | $299K | Sell |
4,600
-300
| -6% | -$19.5K | 0.16% | 64 |
|
|
2018
Q4 | $306K | Hold |
4,900
| – | – | 0.19% | 62 |
|
|
2018
Q3 | $378K | Sell |
4,900
-540
| -10% | -$41.7K | 0.2% | 59 |
|
|
2018
Q2 | $385K | Sell |
5,440
-550
| -9% | -$39K | 0.23% | 58 |
|
|
2018
Q1 | $452K | Sell |
5,990
-4,300
| -42% | -$324K | 0.28% | 53 |
|
|
2017
Q4 | $737K | Hold |
10,290
| – | – | 0.47% | 38 |
|
|
2017
Q3 | $834K | Buy |
+10,290
| New | +$834K | 0.58% | 36 |
|